ICH guidelines emphasize a risk assessment approach to safety evaluation. This approach involves identifying potential hazards, assessing the likelihood and severity of adverse effects, and implementing measures to minimize risks. The guidelines provide a structured framework for conducting risk assessments, ensuring that safety considerations are integrated into every stage of the drug development process.
